Skip to content

TRILLIUM THERAPEUTICS INC.

CIK 0001616212

← back to feed
Revenue (TTM)
$148K
+19.4% YoY Q3 Nov 2021
Net Income (TTM)
−$61.08M
−55.8% YoY Q3 Nov 2021
EPS Diluted (TTM)
—
Q3 Nov 2021
Gross Margin
—
Q3 Nov 2021
Operating Margin
-42,179.1%
Q3 Nov 2021
Net Margin
-41,273.0%
Q3 Nov 2021
Free Cash Flow (TTM)
−$23.06M
Q3 Nov 2021
Cash
$93.23M
Q3 Nov 2021
Total Debt
—
Q3 Nov 2021
Shares Outstanding
105M sh
Q3 Nov 2021

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings